ENST00000376131.9:c.209-200857T>C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000376131.9(FGF14):​c.209-200857T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 152,184 control chromosomes in the GnomAD database, including 4,015 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.20 ( 4015 hom., cov: 32)

Consequence

FGF14
ENST00000376131.9 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.240

Publications

1 publications found
Variant links:
Genes affected
FGF14 (HGNC:3671): (fibroblast growth factor 14) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. A mutation in this gene is associated with autosomal dominant cerebral ataxia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
FGF14 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 27A
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 27
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • autosomal recessive cerebellar ataxia
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000376131.9, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000376131.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF14
NM_175929.3
c.209-200857T>C
intron
N/ANP_787125.1Q92915-2
FGF14
NM_001321939.2
c.209-207325T>C
intron
N/ANP_001308868.1
FGF14
NM_001321945.2
c.92-200857T>C
intron
N/ANP_001308874.1A0A9L9PXK7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGF14
ENST00000376131.9
TSL:1
c.209-200857T>C
intron
N/AENSP00000365301.3Q92915-2
FGF14
ENST00000418923.3
TSL:3
c.92-200857T>C
intron
N/AENSP00000516414.1A0A9L9PXK7
FGF14
ENST00000706494.1
c.-59-200857T>C
intron
N/AENSP00000516417.1A0A9L9PX77

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29937
AN:
152066
Hom.:
4015
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0501
Gnomad AMI
AF:
0.295
Gnomad AMR
AF:
0.168
Gnomad ASJ
AF:
0.298
Gnomad EAS
AF:
0.00269
Gnomad SAS
AF:
0.131
Gnomad FIN
AF:
0.231
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.203
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.197
AC:
29926
AN:
152184
Hom.:
4015
Cov.:
32
AF XY:
0.190
AC XY:
14143
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0499
AC:
2073
AN:
41540
American (AMR)
AF:
0.167
AC:
2561
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.298
AC:
1034
AN:
3470
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5192
South Asian (SAS)
AF:
0.131
AC:
629
AN:
4816
European-Finnish (FIN)
AF:
0.231
AC:
2450
AN:
10592
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20409
AN:
67964
Other (OTH)
AF:
0.200
AC:
423
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1132
2264
3397
4529
5661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
652
Bravo
AF:
0.187
Asia WGS
AF:
0.0660
AC:
229
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
9.1
DANN
Benign
0.90
PhyloP100
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs12865694;
hg19: chr13-102728503;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.